NCT04455906View on ClinicalTrials.gov

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

RecruitingOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

March 15, 2027

Study Completion Date

September 15, 2027

Conditions
Atopic Dermatitis
Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Boston Children's Hospital

OTHER